Myconic Capital Corp. Stock Toronto S.E.

Stocks

MEDI

CA62848M1077

Healthcare Facilities & Services

OTC Markets Traded
End-of-day quote Toronto S.E. 2021-02-08 5-day change 1st Jan Change
0.6000 CAD -40.00% Intraday chart for Myconic Capital Corp. -14.29% +66.67%
Manager TitleAgeSince
Chief Executive Officer - 2022-03-30
Director of Finance/CFO 51 2022-06-14
General Counsel - -
Director TitleAgeSince
Director/Board Member 44 2020-09-17
Director/Board Member 39 2021-01-06
Director/Board Member - 2021-05-31
Change 5-day change 1-year change 3-year change Capi.($)
-40.00%-14.29% - - 163
-0.62%-0.50%+76.39%+41.87% 137B
+1.94%+5.18%+16.54%+41.00% 86.43B
-0.56%+0.27%+5.30%+53.35% 28.35B
+1.75%+11.64%+37.55%+72.55% 25.59B
+2.37%+10.43%-7.81%-19.35% 21.59B
+4.36%+25.20%+59.04%+232.10% 20.96B
+0.37%+0.94%+62.78%+136.24% 15.17B
+0.66%-5.22%+3.32%-8.27% 14.47B
-2.02%-0.67%-3.93%-9.28% 13.24B
Average -3.07%+5.39%+27.69%+60.02% 40.27B
Weighted average by Cap. +0.89%+3.66%+41.37%+52.16%

Financials

2020 2021
Net sales - 1.13 0.99 0.93 0.85 1.6 108.48 1.62 11 4.3 53.56 4.25 4.15 185.14
Net income 1.13M 991K 922K 847K 1.59M 108M 1.61M 10.96M 4.28M 53.36M 4.23M 4.14M 184M -31.91M -28.06M -26.12M -23.98M -45.04M -3.06B -45.63M -310M -121M -1.51B -120M -117M -5.22B
Net Debt - -
Logo Myconic Capital Corp.
Wellbeing Digital Sciences Inc. is an evidence-based mental healthcare company. The Company is focused on the development and implementation of clinical treatment solutions, including psychedelic medicine and digital therapeutics, as supported by clinical research. It operates through three segments: Wellbeing & IRP; KGK Science and Mindscape. It operates medical clinics across North America to help its patients access plant-based medicines, psychedelics, and other forms of mental health care, all of which have the potential to heal them of their physical and/or emotional pain. Its subsidiaries include Mindscape Ketamine & Infusions Therapy LLC, KGK Science Inc. and Integrated Rehab and Performance Ltd. It is supported by a network of North American clinics that provide therapies and other types of treatment to patients, as well as through a contract research organization that offers clinical trials services to clients pursuing drug development.
Employees
-